Prazosin for Raynaud's phenomenon in progressive systemic sclerosis

BACKGROUND: Scleroderma is a connective tissue disease causing fibrosis and commonly affects the skin and internal organs such as the GI tract, lungs, kidney and heart. Most people with scleroderma also have raynaud's phenomenon (RP). One of the possible treatment options for RP in scleroderma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Harding, Sarah E, Tingey, Paul C, Pope, Janet, Fenlon, D, Furst, Dan, Shea, Beverley, Silman, Alan, Thompson, A, Wells, George A
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 1998
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7032637/
https://ncbi.nlm.nih.gov/pubmed/10796398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000956
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados